Corporate social responsibility for nanotechnology oversight

Jennifer Kuzma, Aliya Kuzhabekova

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Growing public concern and uncertainties surrounding emerging technologies suggest the need for socially-responsible behavior of companies in the development and implementation of oversight systems for them. In this paper, we argue that corporate social responsibility (CSR) is an important aspect of nanotechnology oversight given the role of trust in shaping public attitudes about nanotechnology and the lack of data about the health and environmental risks of nanoproducts. We argue that CSR is strengthened by the adoption of stakeholder-driven models and attention to moral principles in policies and programs. In this context, we examine drivers of CSR, contextual and leadership factors that influence CSR, and strategies for CSR. To illustrate these concepts, we discuss existing cases of CSR-like behavior in nanotechnology companies, and then provide examples of how companies producing nanomedicines can exhibit morally-driven CSR behavior.

Original languageEnglish
Pages (from-to)407-419
Number of pages13
JournalMedicine, Health Care and Philosophy
Volume14
Issue number4
DOIs
Publication statusPublished - Nov 2011
Externally publishedYes

Fingerprint

Nanotechnology
nanotechnology
Social Responsibility
social responsibility
Nanomedicine
Environmental Health
Uncertainty
driver
stakeholder
uncertainty
leadership
Technology
lack
health

Keywords

  • Corporate social responsibility
  • Nanotechnology
  • Oversight

ASJC Scopus subject areas

  • Health Policy
  • Education
  • Health(social science)

Cite this

Corporate social responsibility for nanotechnology oversight. / Kuzma, Jennifer; Kuzhabekova, Aliya.

In: Medicine, Health Care and Philosophy, Vol. 14, No. 4, 11.2011, p. 407-419.

Research output: Contribution to journalArticle

@article{05663d620a724965a3b89434aca5c070,
title = "Corporate social responsibility for nanotechnology oversight",
abstract = "Growing public concern and uncertainties surrounding emerging technologies suggest the need for socially-responsible behavior of companies in the development and implementation of oversight systems for them. In this paper, we argue that corporate social responsibility (CSR) is an important aspect of nanotechnology oversight given the role of trust in shaping public attitudes about nanotechnology and the lack of data about the health and environmental risks of nanoproducts. We argue that CSR is strengthened by the adoption of stakeholder-driven models and attention to moral principles in policies and programs. In this context, we examine drivers of CSR, contextual and leadership factors that influence CSR, and strategies for CSR. To illustrate these concepts, we discuss existing cases of CSR-like behavior in nanotechnology companies, and then provide examples of how companies producing nanomedicines can exhibit morally-driven CSR behavior.",
keywords = "Corporate social responsibility, Nanotechnology, Oversight",
author = "Jennifer Kuzma and Aliya Kuzhabekova",
year = "2011",
month = "11",
doi = "10.1007/s11019-011-9330-3",
language = "English",
volume = "14",
pages = "407--419",
journal = "Medicine, Healthcare and Philosophy",
issn = "1386-7423",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Corporate social responsibility for nanotechnology oversight

AU - Kuzma, Jennifer

AU - Kuzhabekova, Aliya

PY - 2011/11

Y1 - 2011/11

N2 - Growing public concern and uncertainties surrounding emerging technologies suggest the need for socially-responsible behavior of companies in the development and implementation of oversight systems for them. In this paper, we argue that corporate social responsibility (CSR) is an important aspect of nanotechnology oversight given the role of trust in shaping public attitudes about nanotechnology and the lack of data about the health and environmental risks of nanoproducts. We argue that CSR is strengthened by the adoption of stakeholder-driven models and attention to moral principles in policies and programs. In this context, we examine drivers of CSR, contextual and leadership factors that influence CSR, and strategies for CSR. To illustrate these concepts, we discuss existing cases of CSR-like behavior in nanotechnology companies, and then provide examples of how companies producing nanomedicines can exhibit morally-driven CSR behavior.

AB - Growing public concern and uncertainties surrounding emerging technologies suggest the need for socially-responsible behavior of companies in the development and implementation of oversight systems for them. In this paper, we argue that corporate social responsibility (CSR) is an important aspect of nanotechnology oversight given the role of trust in shaping public attitudes about nanotechnology and the lack of data about the health and environmental risks of nanoproducts. We argue that CSR is strengthened by the adoption of stakeholder-driven models and attention to moral principles in policies and programs. In this context, we examine drivers of CSR, contextual and leadership factors that influence CSR, and strategies for CSR. To illustrate these concepts, we discuss existing cases of CSR-like behavior in nanotechnology companies, and then provide examples of how companies producing nanomedicines can exhibit morally-driven CSR behavior.

KW - Corporate social responsibility

KW - Nanotechnology

KW - Oversight

UR - http://www.scopus.com/inward/record.url?scp=80053920526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053920526&partnerID=8YFLogxK

U2 - 10.1007/s11019-011-9330-3

DO - 10.1007/s11019-011-9330-3

M3 - Article

C2 - 21626458

AN - SCOPUS:80053920526

VL - 14

SP - 407

EP - 419

JO - Medicine, Healthcare and Philosophy

JF - Medicine, Healthcare and Philosophy

SN - 1386-7423

IS - 4

ER -